What is your approach to using newer atypical antipsychotics in the treatment of schizophrenia?   

e.g. latuda (lurasidone), fanapt (iloperidone), vraylar (cariprazine), rexulti (brexpiprazole), caplyta (lumateperone), or saphris (asenapine), lybalvi (olanzapine/samidorphan)

Are there specific patient factors or indications that would influence you to choose one of these newer antipsychotics? How effective are they in your personal experience?